Intrexon News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

12.12.16	Oxitec's Medfly Ready for Open Field Trials (PR Newswire)
30.11.16	Oxitec Announces Friendly™ Aedes Project is Supported By 92.8% of Piracicaba’s Population (PR Newswire)
21.11.16	Board of Florida Keys Mosquito Control District Approves Investigational Agreement for Effectiveness Trial of Oxitec's Friendly™ Mosquitoes in Monroe County, Florida (PR Newswire)
21.11.16	Board of Florida Keys Mosquito Control District Approves Investigational Agreement for Effectiveness Trial of Oxitec's Friendly™ Mosquitoes in Monroe County, Florida (PR Newswire)
15.04.16	D-Day Awaits CHMA, APHB Abandons XON Collaboration, More On The Way For Opdivo (RTTNews)
29.02.16	EARNINGS SUMMARY: Details of Intrexon Corporation Q4 Earnings Report (RTTNews)
09.11.15	EARNINGS SUMMARY: Details of Intrexon Corporation Q3 Earnings Report (RTTNews)
29.09.15	ZSAN Abuzz With Activity, Titan Gets FDA Date, ESPR Down After Hours (RTTNews)
20.08.15	IEP, Dominion In Agreement To Commercialize Method For Natural Gas Bioconversion (RTTNews)
11.08.15	Intrexon Q2 Loss Narrows - Quick Facts (RTTNews)
10.08.15	Intrexon To Buy Oxitec (RTTNews)
21.07.15	BMRN Expands Breast Cancer Trial, EXEL's Meteor Shines, HZNP Widens Horizons (RTTNews)
30.03.15	Merck Serono findet Partner für Suche nach Krebsmittel (Dow Jones)
30.03.15	Intrexon & Merck Serono Collaborate For Development Of CAR-T Therapy (RTTNews)
03.03.15	BMY To Face FDA, XON Springs A Surprise, AERI Awaits Rocket To Deliver (RTTNews)
02.03.15	AMGN's Kyprolis Better Than Rival, KOOL Put On Notice, XON Inks Fruity Deal (RTTNews)
27.02.15	Intrexon To Buy Canadian Agriculture Biotechnology Company (RTTNews)
16.02.15	Did You Make The Most Of These Secondary Offerings? (RTTNews)
26.01.15	Intrexon To Buy Rest Of Exemplar Genetics (RTTNews)
22.01.15	XON Prices Offering At $27/Share (RTTNews)
14.01.15	MÄRKTE USA/Wall Street von schwachen Einzelhandelsdaten belastet (Dow Jones)
14.01.15	MÄRKTE USA/Wall Street dürfte hoch volatil bleiben (Dow Jones)
15.08.14	Intrexon Loss Widens On Expenses - Update (RTTNews)
14.08.14	Intrexon Posts Wider Q2 Loss On Noncash Charges - Quick Facts (RTTNews)
31.03.14	Intrexon Q4 Loss Narrows (RTTNews)
07.03.14	Intrexon Closes Medistem Acquisition (RTTNews)
31.12.13	Agilis Biotherapeutics Names George Zorich CEO - Quick Facts (RTTNews)
23.12.13	ARIA On Resurrection, XON Opens Wallet, NUVA In Work Mode, ORMP's Sweet Tidings (RTTNews)
17.10.13	Soligenix Announces Formation of International Melioidosis Scientific Advisory Board (PR Newswire)
07.10.13	Clinical Study Updates, Trial Enrollments, NDA Submissions, Partnerships, and Formation of New Subsidiaries - Research Report on BioMarin, Alnylam, Vertex, Illumina, and Intrexon (PR Newswire)
02.10.13	Intrexon Establishes "Living Arts" Company, BioPop, to Create Consumer Products Inspired by Nature and Made Possible through Science (PR Newswire)
02.10.13	ANAC, SLXP Get FDA Date, CERS On A High, MACK On Watch, OGEN And XON Team Up (RTTNews)
01.10.13	Oragenics and Intrexon to Develop Genetically Modified Probiotics (PR Newswire)
01.10.13	Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases (PR Newswire)
20.09.13	Intrexon Loss Narrows - Quick Facts (RTTNews)
13.09.13	Intrexon and Rentokil Enter into Research and Development Agreement to Explore a New Generation of Highly-Effective, Sustainable Pest Controls (PR Newswire)
14.08.13	Synthetic Biologics Reports Second Quarter 2013 Financial Results and Operational Update (PR Newswire)
13.08.13	Intrexon Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option by Underwriters (PR Newswire)
08.08.13	Intrexon Prices IPO At $16/share, At Top End Of Range (RTTNews)
08.08.13	Intrexon Prices Initial Public Offering (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’296.50	2.21 %	K V
ABB	50.08	1.21 %	K V
Holcim	89.06	1.11 %	K V
Roche Hldg G	266.90	0.95 %	K V
UBS Group	29.67	0.78 %	K V
Givaudan	3’887.00	-0.41 %	K V
Zurich Insur Gr	548.00	-0.69 %	K V
Geberit	509.20	-0.86 %	K V
Sonova Hldg	294.60	-1.14 %	K V
Logitech Intl	78.86	-1.28 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Intrexon Corp

Aktien Top/Flop

Meistgelesene Nachrichten